Reported Reactions

Devices › Device types

FDA product code JPA · class 2 · Hematology

System, multipurpose for in vitro coagulation studies: medical device reports filed with FDA

7,801 reports carry this product code, 1996–2026; 7 brands with a page.

7,801
reports with this product code
0% of all MAUDE reports
13
reports, 12 months to August 2026
6 in the 12 months before
91.9%
classified as malfunction
62.3% across all reports
0.5%
classified as death, as reported
0.9% across all reports

Product code JPA is FDA's classification for "System, multipurpose for in vitro coagulation studies" (hematology panel), a class 2 device. 7,801 medical device reports carry this product code, 0% of the MAUDE database, from March 1996 to July 2026.

13 reports arrived in the 12 months to August 2026, up 117% from 6 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (91.9%), injury (6.3%) and other (0.7%). 7 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Inratio2,74000.1%85.8%
Coaguchek S System2,49200%99.7%
Coaguchek Pt Test Strips86200.1%96.2%
Inratio215000.2%83.1%
Coaguchek Xs System11620.1%97.6%
Protime Microcoagulation System7400.5%94.3%
I-Stat Pt/Inr Cartridge3400%98.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Roche Diagnostics4,03051.7%
Hemosense1,59620.5%
Biosite1,13014.5%
International Technidyne4435.7%
Dade Behring390.5%
Abbott Point Of Care260.3%
Siemens Healthcare Diagnostics Products100.1%
Haemonetics90.1%
Beckman Coulter20%
Biomerieux20%
Abbott10%
Alere San Diego10%

Reports by month, five years

035Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 22022Jan 2022: 2Feb 2022: 0Mar 2022: 1Apr 2022: 1May 2022: 0Jun 2022: 0Jul 2022: 1Aug 2022: 0Sep 2022: 0Oct 2022: 1Nov 2022: 0Dec 2022: 32023Jan 2023: 0Feb 2023: 1Mar 2023: 0Apr 2023: 2May 2023: 0Jun 2023: 1Jul 2023: 0Aug 2023: 3Sep 2023: 0Oct 2023: 1Nov 2023: 3Dec 2023: 02024Jan 2024: 0Feb 2024: 2Mar 2024: 1Apr 2024: 1May 2024: 0Jun 2024: 0Jul 2024: 1Aug 2024: 2Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 12025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 1May 2025: 0Jun 2025: 3Jul 2025: 1Aug 2025: 0Sep 2025: 0Oct 2025: 5Nov 2025: 1Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 1Jun 2026: 1Jul 2026: 3Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.5%39
Injury6.3%494
Malfunction91.9%7,168
Other0.7%57
Not given0.6%43

Who filed

Manufacturer report98.8%7,709
Voluntary report0.7%52
User facility report0%0
Distributor report0.2%12
Not given0.4%28

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
High test results2,07726.6%
Incorrect or inadequate test results1,90224.4%
Incorrect, inadequate or imprecise result or readings1,78622.9%
Low test results1,30916.8%
Replace1,28416.5%
Measurements, inaccurate4395.6%
Improper device output2072.7%
Device displays incorrect message650.8%
High readingsreadings were too high620.8%
Other (for use when an appropriate device code cannot be identified)440.6%
Imprecision310.4%
Improper or incorrect procedure or method290.4%
Coagulation in device or device ingredient280.4%
Component(s), broken270.3%
Device operates differently than expectedthe device behaved unexpectedly260.3%
Insufficient device problem information260.3%
Low readingsreadings were too low230.3%
Breakthe device broke200.3%
Nonstandard device200.3%
Smoking100.1%

Questions about system, multipurpose for in vitro coagulation studies reports

What is product code JPA?

FDA's classification code for "System, multipurpose for in vitro coagulation studies", class 2, reviewed by the hematology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

7,801 reports through August 2026, 13 of them in the latest 12 months.

Which brands appear most often?

Inratio (2,740), Coaguchek S System (2,492), Coaguchek Pt Test Strips (862), Inratio2 (150) and Coaguchek Xs System (116). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.